Intellia Therapeutics Inc buy Chardan Capital
Start price
27.02.26
/
50%
€11.72
Target price
27.02.27
€22.04
Performance (%)
-1.92%
Price
25.03.26
€11.50
Summary
This prediction is currently active. With a performance of -1.92%, the BUY prediction by Chardan_Capital is trending in the wrong direction. This prediction currently runs until 27.02.27. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intellia Therapeutics Inc | -0.905% |
| iShares Core DAX® | -1,03 % |
| iShares Nasdaq 100 | -1,95 % |
| iShares Nikkei 225® | -0,42 % |
| iShares S&P 500 | -1,20 % |
Comments by Chardan_Capital for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its "buy" rating reaffirmed by Chardan Capital. They now have a $26.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Chardan_Capital for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€12.31
27.10.25
27.10.25
€41.25
27.10.26
27.10.26
-6.62%
25.03.26
25.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.60
09.05.25
09.05.25
€60.64
09.05.26
09.05.26
51.25%
25.03.26
25.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.69
28.02.25
28.02.25
€65.29
28.02.26
28.02.26
13.42%
01.03.26
01.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.46
18.11.24
18.11.24
€86.10
18.11.25
18.11.25
-46.48%
19.11.25
19.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€35.98
07.08.23
07.08.23
€97.28
07.08.24
07.08.24
-45.29%
08.08.24
08.08.24